Marks Group Wealth Management’s GXO Logistics GXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$222K Hold
5,000
– – 0.02% 348
2026
Q2
$254K Sell
5,000
-100
-2% -$5.18K 0.02% 334
2026
Q1
$264K Hold
5,100
– – 0.03% 309
2025
Q4
$268K Hold
5,100
– – 0.03% 299
2025
Q3
$270K Buy
5,100
+100
+2% +$5.14K 0.03% 267
2025
Q2
$244K Buy
+5,000
New +$199K 0.02% 273
2025
Q1
– Sell
-5,000
Closed -$218K – 305
2024
Q4
$218K Hold
5,000
– – 0.02% 278
2024
Q3
$260K Hold
5,000
– – 0.02% 270
2024
Q2
$252K Hold
5,000
– – 0.03% 274
2024
Q1
$269K Hold
5,000
– – 0.03% 273
2023
Q4
$306K Hold
5,000
– – 0.03% 262
2023
Q3
$293K Hold
5,000
– – 0.04% 243
2023
Q2
$314K Hold
5,000
– – 0.04% 246
2023
Q1
$252K Hold
5,000
– – 0.03% 258
2022
Q4
$213K Buy
+5,000
New +$201K 0.03% 266
2022
Q3
– Sell
-5,000
Closed -$216K – 287
2022
Q2
$216K Buy
+5,000
New +$277K 0.03% 274

Other funds holding GXO

Marks Group Wealth Management's GXO Position: Q3 2026 in Review

Marks Group Wealth Management held its GXO Logistics (GXO) position steady in Q3 2026 at 5,000 shares worth $222K. The position accounts for 0.02% of the portfolio, ranked #348.

Marks Group Wealth Management first reported a position in GXO in Q2 2022 and has held it in 16 quarters since. The position peaked at $314K in Q2 2023. 363 funds tracked by Wall St. Rank hold GXO as of Q3 2026.

  • Marks Group Wealth Management held 5,000 shares of GXO Logistics worth $222K as of Q3 2026.
  • Marks Group Wealth Management left its GXO Logistics share count unchanged in Q3 2026.
  • GXO Logistics made up 0.02% of Marks Group Wealth Management's portfolio in Q3 2026, its #348 holding.
  • Marks Group Wealth Management first reported a position in GXO Logistics in Q2 2022 and has held it in 16 quarters since.
  • Marks Group Wealth Management's GXO Logistics position peaked at $314K in Q2 2023.
  • 363 funds tracked by Wall St. Rank held GXO Logistics as of Q3 2026.

Based on Marks Group Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.